Regnante Keith

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 33% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Regnante Keith's trades of Keros Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
433.67
Quantity 80,697
Value US$3,387,175
Transaction date
Proposed sale
Price
45.42
Quantity 20,000
Value US$908,322
Transaction date
Proposed sale
Price
47.79
Quantity 20,000
Value US$955,852
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-20 2026-02-18
S Sale
30,669 -46.4%
190.81
US$4,531,752 		30,669 -46.4% 190.81 US$4,531,752
2024-01-04 2024-01-04
PrS Proposed sale
80,697
433.67
US$3,387,175 		80,697 433.67 US$3,387,175
2024-01-08 2023-11-04
PlS Planned sale
16,612 -45.9%
349.95
US$2,366,197 		16,612 -45.9% 349.95 US$2,366,197
2023-06-12 2023-06-09
PlS Planned sale
2,579 -100.0%
47.25
US$121,858 		2,579 -100.0% 47.25 US$121,858
2023-06-12 2023-06-09
PlS Planned sale
1,428 -35.6%
46.46
US$66,345 		1,428 -35.6% 46.46 US$66,345
2023-06-12 2023-06-09
PlS Planned sale
15,993 -80.0%
45.03
US$720,165 		15,993 -80.0% 45.03 US$720,165
2023-06-09 2023-06-09
PrS Proposed sale
20,000
45.42
US$908,322 		20,000 45.42 US$908,322
2023-06-12 2023-06-08
PlS Planned sale
2,699 -100.0%
48.65
US$131,306 		2,699 -100.0% 48.65 US$131,306
2023-06-12 2023-06-08
PlS Planned sale
17,301 -86.5%
47.66
US$824,566 		17,301 -86.5% 47.66 US$824,566
2023-06-08 2023-06-08
PrS Proposed sale
20,000
47.79
US$955,852 		20,000 47.79 US$955,852
2019-02-21 2019-02-19
PlS Planned sale
1,298 -7.6%
36.84
US$47,818 		1,298 -7.6% 36.84 US$47,818